HTFL
Heartflow, Inc. Common Stock NASDAQ Listed Aug 7, 2025$50.75
+2.38%
vs $49.57
Mkt Cap $4.4B
52w Low $20.13
95.4% of range
52w High $52.22
50d MA $36.85
200d MA $30.66
P/E (TTM)
—
EV/EBITDA
—
P/B
62.2x
Debt/Equity
0.1x
ROE
-38.9%
P/FCF
-316.7x
RSI (14)
59.30
ATR (14)
$2.55
Beta
1.03
50d MA
$36.85
200d MA
$30.66
Avg Volume
2.4M
HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries. The company's platform provides insights on blood flow, stenosis, and plaque volume and composition by overcoming the limitations of traditional non-invasive imaging tests. The company was founded in 2007 and is headquartered in Mountain View, California.
331 E. Evelyn Avenue · Mountain View, CA 94041 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | AMC | -0.13 | -0.07 | +47.6% | 31.01 | +26.0% | +35.7% | -0.3% | +7.8% | +0.7% | +2.8% | — |
| May 14, 2026 | AMC | -0.19 | -0.16 | +14.7% | 32.24 | -9.9% | -12.2% | -9.4% | +3.7% | +2.9% | +6.6% | — |
| Mar 18, 2026 | AMC | -0.19 | -0.12 | +36.0% | 25.47 | -1.8% | +1.6% | +0.5% | +3.1% | +4.3% | -0.8% | — |
| Nov 12, 2025 | AMC | -0.20 | -0.27 | -35.0% | 35.74 | -3.0% | -13.4% | -9.6% | -5.6% | +3.4% | -0.3% | — |
| Sep 19, 2025 | AMC | -0.21 | -0.06 | +71.8% | 32.88 | -0.8% | -4.4% | +14.1% | -3.8% | -1.7% | -2.5% | — |
| Jul 17, 2025 | AMC | -0.21 | -0.46 | -116.0% | — | — | — | — | — | — | — | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 9 | UBS | Reiterates | Neutral | $55 | $47.75 | $47.25 | -1.0% | -2.3% | -2.5% | +9.7% | -0.7% | -2.4% |
| Jul 31 | Robert W. Baird | Initiates | Outperform | $34 | $25.83 | $26.46 | +2.4% | -2.3% | +6.1% | +1.9% | -0.4% | +0.1% |
| May 4 | William Blair | Initiates | Outperform | — | $28.67 | $28.99 | +1.1% | +1.0% | +3.5% | +1.1% | -1.0% | -1.6% |
| Mar 19 | Canaccord Genuity | Maintains | Buy → Buy | — | $25.47 | $25.00 | -1.8% | +1.6% | +0.5% | +3.1% | +4.3% | -0.8% |
| Mar 19 | JP Morgan | Maintains | Overweight → Overweight | — | $25.47 | $25.00 | -1.8% | +1.6% | +0.5% | +3.1% | +4.3% | -0.8% |
| Mar 19 | Wells Fargo | Maintains | Overweight → Overweight | — | $25.47 | $25.00 | -1.8% | +1.6% | +0.5% | +3.1% | +4.3% | -0.8% |
| Mar 9 | Canaccord Genuity | Maintains | Buy → Buy | — | $22.98 | $23.09 | +0.5% | +0.9% | -2.5% | -1.7% | -6.4% | -1.4% |
| Nov 13 | Canaccord Genuity | Maintains | Buy → Buy | — | $35.74 | $34.65 | -3.0% | -13.4% | -9.6% | -5.6% | +3.4% | -0.3% |
| Nov 13 | JP Morgan | Maintains | Overweight → Overweight | — | $35.74 | $34.65 | -3.0% | -13.4% | -9.6% | -5.6% | +3.4% | -0.3% |
| Nov 13 | Stifel | Maintains | Buy → Buy | — | $35.74 | $34.65 | -3.0% | -13.4% | -9.6% | -5.6% | +3.4% | -0.3% |
| Sep 22 | Canaccord Genuity | Maintains | Buy → Buy | — | $32.88 | $32.62 | -0.8% | -4.4% | +14.1% | -3.8% | -1.7% | -2.5% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Verghese VikramOff | Chief Financial Officer | Sell | 668 | $50.01 | $33K | 179,528 | -0.06% | — |
| Sep 14, 2026 | Verghese VikramOff | Chief Financial Officer | Sell | 4,593 | $50.24 | $231K | 180,196 | -0.06% | — |
| Sep 11, 2026 | Verghese VikramOff | Chief Financial Officer | Sell | 29,714 | $50.06 | $1.5M | 184,789 | -0.06% | — |
| Sep 11, 2026 | Farquhar John C.M.Dir/Off | Chief Executive Officer | Sell | 3,890 | $50.00 | $194K | 321,914 | -2.44% | — |
| Sep 10, 2026 | Farquhar John C.M.Dir/Off | Chief Executive Officer | Sell | 35,010 | $46.42 | $1.6M | 325,804 | -2.44% | — |
| Sep 8, 2026 | Verghese VikramOff | Chief Financial Officer | Sell | 6,640 | $50.03 | $332K | 214,503 | +9.65% | +2.63% |
| Aug 21, 2026 | Farquhar John C.M.Dir/Off | Chief Executive Officer | Sell | 27,230 | $50.00 | $1.4M | 360,814 | -1.90% | +0.08% |
| Aug 18, 2026 | Farquhar John C.M.Dir/Off | Chief Executive Officer | Sell | 32,676 | $45.00 | $1.5M | 388,044 | +6.30% | -1.72% |
| Aug 17, 2026 | Rogers CampbellOff | Chief Medical Officer | Sell | 9,219 | $41.23 | $380K | 86,459 | +2.79% | -1.90% |
| Aug 14, 2026 | Farquhar John C.M.Dir/Off | Chief Executive Officer | Sell | 15,560 | $39.06 | $608K | 420,720 | +0.66% | -0.62% |
| Aug 10, 2026 | Farquhar John C.M.Dir/Off | Chief Executive Officer | Sell | 22,562 | $28.31 | $639K | 436,280 | +3.89% | +0.66% |
| Jul 10, 2026 | Farquhar John C.M.Dir/Off | Chief Executive Officer | Sell | 22,562 | $27.75 | $626K | 435,373 | -2.56% | -1.29% |
| May 18, 2026 | Rogers CampbellOff | Chief Medical Officer | Sell | 9,219 | $28.34 | $261K | 78,731 | +6.65% | +8.37% |
| May 11, 2026 | Farquhar John C.M.Dir/Off | Chief Executive Officer | Sell | 22,562 | $29.12 | $657K | 519,397 | +3.33% | +2.93% |
| Apr 30, 2026 | Bain Capital Life Sciences Investors, LLC | — | Sell | 56,224 | $30.05 | $1.7M | 8,448,158 | -3.66% | -1.02% |
| Apr 30, 2026 | Bain Capital Life Sciences Investors, LLC | — | Sell | 892,533 | $29.18 | $26.0M | 8,504,382 | -3.66% | -1.02% |
| Apr 29, 2026 | Bain Capital Life Sciences Investors, LLC | — | Sell | 797,133 | $29.37 | $23.4M | 9,396,915 | -3.66% | -1.02% |
| Apr 28, 2026 | Bain Capital Life Sciences Investors, LLC | — | Sell | 254,110 | $30.51 | $7.8M | 10,194,048 | -3.66% | -1.02% |
8-K · 2.02
!! High
Heartflow, Inc. -- 8-K 2.02: Earnings Results
May 14
8-K
Unknown — 8-K Filing
HeartFlow's full-year 2025 results will reveal revenue growth, profitability progress, and whether AI-driven cardiac imaging adoption is accelerating—critical metrics for valuing this high-growth medical technology company.
Mar 18
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | 5,197,747 | $153M | New | Jun 2026 |
| 2 | Fmr Llc | 5,397,802 | $131M | Added | Mar 2026 |
| 3 | Vanguard Portfolio Management Llc | 3,584,428 | $105M | Added | Jun 2026 |
| 4 | Vanguard Capital Management Llc | 2,753,206 | $81M | Added | Jun 2026 |
| 5 | Janus Henderson Group Plc | 2,180,976 | $53M | New | Mar 2026 |
| 6 | Point72 Asset Management, L.p. | 1,721,279 | $51M | Added | Jun 2026 |
| 7 | Citadel Advisors Llc | 1,599,766 | $47M | Added | Jun 2026 |
| 8 | Invesco Ltd. | 1,913,090 | $47M | Added | Mar 2026 |
| 9 | Morgan Stanley | 1,491,848 | $43M | Reduced | Dec 2025 |
| 10 | Nuveen, Llc | 1,353,168 | $40M | Added | Jun 2026 |
| 11 | Bnp Paribas Asset Management Holding S.a. | 931,160 | $27M | New | Jun 2026 |
| 12 | Millennium Management Llc | 922,893 | $27M | Reduced | Jun 2026 |
| 13 | Franklin Resources Inc | 793,721 | $19M | Added | Mar 2026 |
| 14 | Xxec, Inc. | 599,194 | $18M | Added | Jun 2026 |
| 15 | Ensign Peak Advisors, Inc | 690,466 | $17M | Reduced | Mar 2026 |
| 16 | Next Century Growth Investors Llc | 652,969 | $16M | New | Mar 2026 |
| 17 | Massachusetts Financial Services Co /ma/ | 498,812 | $15M | New | Jun 2026 |
| 18 | Champlain Investment Partners, Llc | 567,424 | $14M | New | Mar 2026 |
| 19 | Rtw Investments, Lp | 495,000 | $12M | — | Mar 2026 |
| 20 | Renaissance Technologies Llc | 382,700 | $11M | New | Jun 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$4.38B
Enterprise Value
$18.54B
P/E (TTM)
—
Forward P/E
—
PEG Ratio
11.42x
P/B
62.21x
P/S
20.64x
P/FCF
-316.75x
EV/EBITDA
—
Shares Out
368.5M
Financials (TTM)
Revenue
$212.1M
Net Income
-$118.4M
EBITDA
-$108.2M
Free Cash Flow
-$59.0M
Op Cash Flow
-$54.0M
EPS Basic
$-1.37
EPS Diluted
$-1.42
EPS Forward
$-0.56
Gross Margin
80.1%
Op Margin
-34.3%
Net Margin
-55.8%
Balance Sheet
Total Assets
$359.5M
Total Liab.
$58.8M
Total Equity
$300.6M
Cash
$176.8M
LT Debt
$16.1M
Book Value/Sh
$0.82
Debt/Equity
0.07x
Current Ratio
5.20
Quick Ratio
5.20
Returns & Growth
ROE
-38.9%
ROA
-32.5%
ROIC
-19.8%
Rev Growth YoY
+39.9%
EPS Growth YoY
+8.1%
Price Returns
2W
+2.1%
1M
+11.5%
3M
+50.0%
6M
+96.0%
12M
+54.3%
Technicals
52W High
$52.22
52W Low
$20.13
50d MA
$36.85
200d MA
$30.66
RSI (14)
59.30
ATR (14)
$2.55
Beta
1.03
Avg Volume
2.4M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$38.00
High
$38.00
Low
$38.00
Median
$38.00
Data updated apr 25, 2026 2:13pm
· Source: financialmodelingprep.com